Literature DB >> 12601757

Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity.

Assunta Maria Di Biase1, Agostina Pietrantoni, Antonella Tinari, Rosa Siciliano, Piera Valenti, Giovanni Antonini, Lucilla Seganti, Fabiana Superti.   

Abstract

Lactoferrin, a member of the transferrin family of approximately 80 kDa, consists of a single polypeptide chain folded in two symmetric, globular lobes (N- and C-lobes), each able to bind one ferric ion. This glycoprotein, found in physiological fluids of mammals, plays an important role in immune regulation and in defense mechanisms against bacteria, fungi, parasites, and viruses. Although the antiviral activity of lactoferrin is one of the major biological functions of such protein, the mechanism of action is still under debate. We have investigated both the role of tryptic fragments of bovine lactoferrin and the mechanism of lactoferrin antiviral effect toward adenovirus infection in HEp-2 cells. The results obtained demonstrated that the anti-adenovirus activity of lactoferrin is mediated by the N-terminal half of the protein as the N-lobe was able to inhibit adenovirus infection, even if at lower extent than undigested lactoferrin, whereas C-lobe was ineffective. The results also showed that the anti-adenovirus action of lactoferrin and of its N-terminal peptide lactoferricin took place on virus attachment to cell membrane, mainly through competition for common glycosaminoglycan receptors. The data provide evidence that the anti-adenovirus activity of lactoferrin is mediated mainly by the cluster of positive charges at the N-terminus of whole molecule and that the N-terminal peptide lactoferricin alone is sufficient to prevent infection. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601757     DOI: 10.1002/jmv.10337

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  16 in total

1.  Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides.

Authors:  Agostina Pietrantoni; Assunta Maria Di Biase; Antonella Tinari; Magda Marchetti; Piera Valenti; Lucilla Seganti; Fabiana Superti
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN.

Authors:  William C Adams; Emily Bond; Menzo J E Havenga; Lennart Holterman; Jaap Goudsmit; Gunilla B Karlsson Hedestam; Richard A Koup; Karin Loré
Journal:  J Gen Virol       Date:  2009-03-12       Impact factor: 3.891

3.  Lactoferrin conjugated with 40-kDa branched poly(ethylene glycol) has an improved circulating half-life.

Authors:  Yasuhiro Nojima; Yosuke Suzuki; Kazuhiro Yoshida; Fumiko Abe; Tuneo Shiga; Takashi Takeuchi; Akihiko Sugiyama; Hirohiko Shimizu; Atsushi Sato
Journal:  Pharm Res       Date:  2009-06-25       Impact factor: 4.200

4.  Revealing the Specificity of a Range of Antimicrobial Peptides in Lipid Nanodiscs by Native Mass Spectrometry.

Authors:  Lawrence R Walker; Michael T Marty
Journal:  Biochemistry       Date:  2020-06-01       Impact factor: 3.162

Review 5.  Antimicrobial peptides and their potential application in antiviral coating agents.

Authors:  Emanuelle D Freitas; Rogério A Bataglioli; Josephine Oshodi; Marisa M Beppu
Journal:  Colloids Surf B Biointerfaces       Date:  2022-07-08       Impact factor: 5.999

6.  Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells.

Authors:  Cecilia Johansson; Mari Jonsson; Marko Marttila; David Persson; Xiao-Long Fan; Johan Skog; Lars Frängsmyr; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.

Authors:  Jamie S Mader; Daniel Smyth; Jean Marshall; David W Hoskin
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis.

Authors:  Kabilan Velliyagounder; Jeffrey B Kaplan; David Furgang; Diana Legarda; Gill Diamond; Ruth E Parkin; Daniel H Fine
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 9.  Effect of lactoferrin on enteric pathogens.

Authors:  Theresa J Ochoa; Thomas G Cleary
Journal:  Biochimie       Date:  2008-04-18       Impact factor: 4.079

Review 10.  Antiviral properties of lactoferrin--a natural immunity molecule.

Authors:  Francesca Berlutti; Fabrizio Pantanella; Tiziana Natalizi; Alessandra Frioni; Rosalba Paesano; Antonella Polimeni; Piera Valenti
Journal:  Molecules       Date:  2011-08-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.